Article
Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer.
PLoS genetics - 1 Feb 2020
Fang Hu, Barbour Jayne A, Poulos Rebecca C, Katainen Riku, Aaltonen Lauri A, Wong Jason W H
Abstract excerpt
Cancer genomes with mutations in the exonuclease domain of Polymerase Epsilon (POLE) present with an extraordinarily high somatic mutation burden. In vitro studies have shown that distinct POLE mutants exhibit different polymerase activity. Yet, genome-wide mutation patterns and driver mutation formation arising from different POLE mutants remains unclear. Here, we curated somatic mutation calls from 7,345...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
